EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

NCT03266653 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus Infections
Primary Immune Deficiency Disorder

Interventions

DRUG: cytotoxic t-lymphocytes

Sponsor

New York Medical College

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]